Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	536.3	515.82	537.44	563.24	507.86	429.9
Revenue Growth (YoY)	5.20%	-4.02%	-4.58%	10.90%	18.13%	12.63%
Cost of Revenue	149.53	153.42	174.21	183.2	143.72	115.98
Gross Profit	386.77	362.4	363.23	380.04	364.15	313.92
Selling, General & Admin	307.33	452.54	685.53	938.58	793.35	462.39
Research & Development	191.51	232.29	347.02	421.87	367.86	263.94
Operating Expenses	498.84	684.83	1,033	1,360	1,161	726.33
Operating Income	-112.07	-322.43	-669.32	-980.41	-797.06	-412.41
Interest Expense	-	-	-	-	-1.54	-0.67
Interest & Investment Income	9.79	12.21	17.96	9.36	3.46	6.07
Currency Exchange Gain (Loss)	-0.95	-0.1	-0.42	1.55	-0.85	-2.85
Other Non Operating Income (Expenses)	4.09	4.71	0.48	0.25	0.2	2.62
EBT Excluding Unusual Items	-99.13	-305.61	-651.3	-969.25	-795.8	-407.24
Asset Writedown	-35.13	-35.13	-	-	-	-
Pretax Income	-134.26	-340.74	-651.3	-969.25	-795.8	-407.24
Income Tax Expense	5.98	5.89	2.39	1.99	0.9	-
Net Income	-140.24	-346.63	-653.69	-971.23	-796.7	-407.24
Preferred Dividends & Other Adjustments	-	-	-	-	-	64.69
Net Income to Common	-140.24	-346.63	-653.69	-971.23	-796.7	-471.92
Shares Outstanding (Basic)	11	10	10	10	10	7
Shares Outstanding (Diluted)	11	10	10	10	10	7
Shares Change (YoY)	2.94%	0.53%	-1.46%	-0.29%	51.83%	192.26%
EPS (Basic)	-13.30	-33.67	-63.84	-93.47	-76.45	-68.76
EPS (Diluted)	-13.30	-33.67	-63.84	-93.47	-76.45	-68.76
Free Cash Flow	-84.51	-97.68	-263.89	-527.1	-688.81	-149.12
Free Cash Flow Per Share	-8.01	-9.49	-25.77	-50.73	-66.10	-21.73
Gross Margin	72.12%	70.26%	67.58%	67.47%	71.70%	73.02%
Operating Margin	-20.90%	-62.51%	-124.54%	-174.07%	-156.94%	-95.93%
Profit Margin	-26.15%	-67.20%	-121.63%	-172.44%	-156.87%	-109.77%
Free Cash Flow Margin	-15.76%	-18.94%	-49.10%	-93.58%	-135.63%	-34.69%
EBITDA	-100.71	-271.05	-537.87	-859.66	-752.46	-379.95
EBITDA Margin	-18.78%	-52.55%	-100.08%	-152.63%	-148.16%	-88.38%
D&A For EBITDA	11.35	51.39	131.45	120.75	44.6	32.46
EBIT	-112.07	-322.43	-669.32	-980.41	-797.06	-412.41
EBIT Margin	-20.90%	-62.51%	-124.54%	-174.07%	-156.94%	-95.93%
Revenue as Reported	515.82	515.82	537.44	563.24	507.86	429.9

Updated Sep 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q